Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 7
Submit an article Journal homepage
596
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy?

Raoul TibesDepartment of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA
&
Ruben A. MesaDepartment of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USACorrespondence[email protected]
Pages 1178-1187 | Received 20 Jan 2011, Accepted 20 Jan 2011, Published online: 23 May 2011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.